How FDA-Cleared Asurys and Galway R&D Expansion At Boston Scientific (BSX) Has Changed Its Investment Story [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
procedures, and earlier this year committed a €75 million investment to expand cardiovascular R&D facilities in Galway, Ireland with support from IDA Ireland. These moves highlight how Boston Scientific is simultaneously broadening its minimally invasive therapy toolkit and deepening its innovation base in a key global medtech hub. We'll now examine how the FDA clearance of Asurys and expanded Galway R&D footprint may influence Boston Scientific's investment narrative. The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation. Boston Scientific Investment Narrative Recap To own Boston Scientific, you need to believe its minimally invasive portfolio can keep expanding across cardiovascular and urology while margins hold up against tariffs, reimbursement pressure and competition. In the near term, the key catalyst is the upcoming Q1 2026 earnings report, with a major risk around regul
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Here's What Piper Sandler Thinks About Boston Scientific Corp (BSX) Now [Yahoo! Finance]Yahoo! Finance
- Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire
- Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire
- ROSEN, NATIONAL TRIAL LAWYERS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSXGlobeNewswire
- Pacemakers Market to Reach $7.5 Billion by 2030, Driven by Expanding Clinical Indications and Aging Demographics [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 2/4/26 - Beat
BSX
Sec Filings
- 4/2/26 - Form EFFECT
- 4/1/26 - Form 424B3
- 3/30/26 - Form S-4/A
- BSX's page on the SEC website